Navigation Links
New Drug for Diabetes

A new drug under review by the FDA could be one of the most significant advances in diabetes since the discovery of insulin //more than 80 years ago, say doctors involved in the research.

Diabetes is a disease in which the hormone insulin is not made by the body (type 1 diabetes) or the body does not effectively use the insulin it does produce (type 2 diabetes). Researchers, are studying another hormone -- amylin -- to aid in the treatment of diabetes. Amylin is a hormone secreted with insulin by the beta cells in the pancreas. The drug, called SYMLIN, is a man-made version of amylin. Specifically, the drug would be for diabetics -- type 1 or type 2 -- who take insulin injections.

Insulin does not totally suppress the glucagon that the body secretes. Often, diabetics notice that their blood sugar levels tend to be higher after a meal -- even when they take insulin to cover the amount of food eaten. Insulin stimulates the removal of glucose in the blood, but Doctors say, "What's happening is you're making excess glucagon following a meal." The hormone amylin works to control the output of that glucagons. Thus taking insulin without replacing the hormone amylin is like driving a car with only the accelerator and no brakes. They say, "What they are doing is, by taking [amylin] before a meal, they are putting brake fuel back in the brake system."

Studies show, after six months, amylin causes a significant reduction in hbA1c levels. These levels reflect a patient's average blood sugar level over the last three months. The drug currently cannot be mixed with insulin, so patients would need to take additional injections. After five additional studies were conducted, the research was submitted again to the FDA in June 2003. The final decision on this drug, which will be marketed as SYMLIN, is expected no later than December 2003.
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Diabetes on the rise
5. Irregular Periods Linked to Diabetes
6. Cinnamon combats Diabetes
7. Good News For Women With Gestational Diabetes
8. Processed Meat, Diabetes connection Found
9. Pancreatic Cancer may be linked to Diabetes
10. Gestational Diabetes linked to Chromosomal defici
11. A way to slow the progression of Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2017)... ... ... Month and the focus is on prostate cancer. Second only to skin cancer, prostate ... common cause of cancer related death today; lung cancer remains in the number one spot. ... during his lifetime. Those at highest risk are men who have a family ...
(Date:6/24/2017)... ... ... Doorknobs are for convenience, deadbolts are for security. , There are many ... an alarm system installed. But unless there is a working deadbolt lock that is ... Premier Locksmith in Killeen, TX says: “In the majority of home burglaries, intruders use ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived ... loss in these patients. , But how often do ophthalmologists and optometrists in Sweden ... at risk of or with early symptoms of AMD? A study published recently ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant ... Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by long-time ... in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent ... is MD Now’s 28th facility overall and marks the urgent care center's eighth location ... mile North of The Falls shopping mall. The new clinic offers a wide array ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... -- Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), ... selection of stem cells, today provided a corporate update ... March 31 st , 2017. "We ... quarter of 2017," said Dr. Shai Yarkoni, Chief Executive ... of the first blood cancer patient in the recently ...
Breaking Medicine Technology: